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Abstract To investigate the changes of gene expression on
the cerebral vasospasm after subarachnoid hemorrhage, we
used genome-widemicroarray for a canine double-hemorrhage
model and analyzed the data by using a network-based
analysis. Six dogs were assigned to two groups of three
animals: control and hemorrhage. The effects were assessed by
the changes in gene expressions in the artery 7 days after the
first blood injection. Among 23,914 genes, 447 and 66 genes
were up-regulated more than two- and fivefold, respectively,
and 332 and 25 genes were down-regulated more than two-
and fivefold, respectively. According to gene ontology, genes
related to cell communication (P=5.28E-10), host–pathogen
interaction (7.65E-8), and defense–immunity protein activity
(0.000183) were significantly overrepresented. The top high-
level function for the merged network derived from the
network-based analysis was cell signaling, revealing that
the subgroup that regulates the quantity of Ca2+ to have the
strongest association significance (P=4.75E-16). Canine
microarray analysis followed by gene ontology profiling
and connectivity analysis identified several functional groups
and individual genes responding to cerebral vasospasm. Ca2+
regulation may play a key role in these gene expression
changes and may be involved in the pathogenesis of cerebral
vasospasm.
Keywords Canine . Cerebral vasospasm . Gene expression .
Microarray . Network . Ontology . Pathway
Introduction
Although several molecular biological studies have been
reported on the pathogenesis of cerebral vasospasm, the
complete mechanism of cerebral vasospasm remains un-
clear. We have speculated that changes in gene expression
in the arterial wall, especially inflammatory reactions,
contribute to the onset and development of cerebral
vasospasm [1, 6, 14–16]. Recent advancements in micro-
array technology have revolutionized genomics by allowing
researchers to study the expression of thousands of genes
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simultaneously, and it is a very powerful tool to investigate
the regulation changes of gene on the complicated
pathological change such as cerebral vasospasm.
To date, two articles have been published on gene
expression changes seen in intracranial arteries after
subarachnoid hemorrhage (SAH): Macdonald et al. [11]
examined the time course of gene expression after SAH
using one set of arteries for three time points in the primate
model of SAH. Vikman et al. [19] investigated early changes
in the cerebral arteries of rats that occur after SAH. However,
they did not successfully demonstrate conclusive results
related to the pathogenesis of cerebral vasospasm.
The most reliable and common model of cerebral
vasospasm is the canine double-hemorrhage model. Severe
cerebral vasospasm similar to that seen in humans is always
obtained in the canine double-hemorrhage model, which
has been studied profoundly and well-characterized phar-
macologically and pathologically [18]. Therefore, the
constitution of microarray in a large animal such as a dog
is desirable and essential for the molecular biological
knowledge of the cerebral vasospasm.
Nowadays, genetic canine studies are advanced, and
specific genome-wide microarrays are available for labora-
tories. We used genome-wide canine oligonucleotide micro-
arrays to screen for changes in levels of messenger RNA
(mRNA) in the canine double-hemorrhage model [2, 8].
Although identification of a list of individual genes that
show expression change is important, there is an increasing
need to move beyond this level of analysis. Instead of
simply enumerating a list of genes, we want to know how
they interact as parts of complexes, pathways, and
biological networks. For this purpose, the differentially
expressed canine genes were automatically converted to
human genes and imported into genetic pathway analysis
software to identify biological networks and pathways. The
networks described functional relationships between gene
products based on known interactions in the literature [3].
Materials and methods
Canine double-hemorrhage model
The experimental protocol used for animals was evaluated and
approved by the Institutional Animal Care and Use Commit-
tee of Tokyo Women’s Medical University. Care of the
animals and surgical procedures were performed according to
the standards of TokyoWomen’s Medical University Protocol
on Laboratory Animals. Six mongrel dogs were divided into
two groups of three dogs: control and hemorrhage. Dogs
weighing between 7.5 and 17 kg were anesthetized with
intravenous sodium pentobarbital (25 mg/kg). In three dogs,
the cisterna magna was punctured percutaneously, and 0.3 ml/
kg of cerebrospinal fluid was removed by spontaneous egress.
After that, 0.5 ml/kg of fresh autologous arterial non-
heparinized blood was injected into the cisterna magna at a
rate of 5 ml/min. The dogs were tilted with their tail up for
15 min. The catheter was then removed, and the animals were
allowed to recover. These animals were killed on day 7 after
injections of blood on days 0 and 2. An angiography of the
cerebral arteries of each animal was performed on day 0 and
before the animal was killed [1, 14, 15].
Vessel caliber assessment
With a calibrated optical micrometer, the diameters of the
basilar arteries were measured on the angiographic films at
three separate, equally spaced locations along the artery by an
experienced person who was blinded to the treatment groups.
The average diameter value at each location was used.
Comparisons between the two groups were performed using
paired or unpaired Student’s t test. Statistical analysis was
performed using Statistical Package for the Social Sciences
(Tokyo, Japan). Values are expressed as mean ± SD. Differ-
ences were considered significant when the p value was
<0.05.
RNA isolation from the canine basilar artery
The animals were killed by injecting 100 mg/kg pentobarbital,
exsanguinated, and perfused with 2,500 to 3,000 ml physio-
logical saline. Total RNAwas isolated from individual basilar
arteries of each group using trizol (Gibco BRL) according to
the manufacturer’s instructions. Possible traces of genomic
DNA contaminating the RNA preparations were removed by
DNase I (Promega) digestion.
Canine microarray
An oligonucleotide (25-mer) canine array was used, which
was constructed by Affymetrix. A total of 23,836 dog-
specific probe sets were tiled on the array, including sequences
from GenBank, dbEST, and Lion Bioscience. Fifty nano-
grams of total RNAwas reverse transcribed into double-strand
complementary DNA (cDNA) using Megascript T7 Kit and
Two-Cycle cDNA Synthesis Kit, and Eukaryotic Poly-A
RNA Control Kit. Biotinylated complementary RNA was
synthesized using GeneChip Expression 3′-amplification
reagent for IVT labeling kit and fragmented before overnight
hybridization (45°C, 16 h, 60 rpm) with canine array using
GeneChip Hybridization Oven 640. As per the “Affymetrix
GeneChip Expression Analysis Technical Manual,” arrays
were washed and stained using streptavidin–phycoerythin.
Scans were performed using an Affymertrix GeneChip
Scanner 3000, and expression value for each gene was
calculated by GeneChip Operating Software ver.1.2.
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Data analysis
At first, each signal of every treated group was normalized
by dividing the signal of one control group, C1, and when
the signal of each sample in the hemorrhage group (n=3)
were expressed more than two- or fivefold, or less than half or
one fifth of that in the control group (n=3), these genes were
determined as two- or fivefold over- and underexpressed
compared to the control group. The more than two- and
fivefold differentially expressed values (up and down)
address each case and control sample. As an example,
twofold up-regulated means that every single expression
value of the case samples was at least twofold higher than
the highest expression value of the control samples.
Expression signal intensities for each gene were averaged.
Averaged expression values of the hemorrhage group were
compared with those of the control group, and thus, we
calculated the expression ratios (H/C). We analyzed and
classified these genes on the basis of gene ontology (GO,
http://www.geneontology.org/). Functional annotations of the
altered transcripts were carried out using GeneSpring GX
software (version 7.3, Agilent Technologies, CA, USA),
which validated the occurrence of each biological category
within a queried group of genes by using the Fisher’s exact
test. For the Ingenuity network and pathway analysis, the
moderately changed or unregulated genes play an equal role
with the highly significantly regulated genes in constructing
gene networks and thus result in irrelevant networks.
Therefore, a data set containing only the identifiers of the
significantly up- or down-regulated genes with their
corresponding fold changes (in our case, over twofold) was
uploaded as a tab-delimited text file into the Ingenuity
software (http://www.ingenuity.com). This web-delivered
application makes use of the Ingenuity Pathways Knowledge
Base (IPKB) containing large amounts of individually
modeled relationships between gene objects (e.g., genes,
mRNAs, and proteins) to dynamically generate significant
biological networks and canonical pathways, which is a core
pathway established for a given molecule in the cell in which
molecular interactions occur in a linear and stepwise manner.
The submitted genes that are mapped to the corresponding
gene objects in the IPKB are called “focus genes.” The focus
genes are used as the starting point for generating biological
networks. To start building networks, Ingenuity software
queries the IPKB for interactions between focus genes and
all the other genes stored in the IPKB, and generates a set of
networks with a maximum network size of 35 genes. A p
value for each network and canonical pathway is calculated
according to the fit of the user’s set of significant genes. This
is done by comparing the number of focus genes that
participate in a given network or pathway, relative to the total
number of occurrences of those genes in all networks or
pathways stored in the IPKB. The score of the network is
displayed as the negative log10 of the p value, indicating the
likelihood of the focus genes in a network being found
together due to random chance. Therefore, scores of two
have at least 99% confidence of not being generated by
chance alone. In the current study, a score of 24 or higher
was used to select highly significant biological networks
playing a role in this model for cerebral vasospasm.
Results
Assessment of cerebral vasospasm
There was no difference in vessel caliber at the baseline
between the control and the hemorrhage groups (unpaired
t test). There was a significant difference in vessel caliber
between the baseline of the control group and day 7 of the
hemorrhage group (p=0.003, unpaired t test). The mean
diameter of the basilar arteries on day 7, as a percentage of
Fig. 1 Graph showing changes in the vessel caliber of basilar arteries
in a canine double-hemorrhage model. Bars represent the mean ± SD
(n=3, each group). There was no difference in vessel caliber at the
baseline between groups (unpaired t test). There was a significant
difference in vessel caliber between the baseline of the control group
and day 7 of the hemorrhage group (p=0.003, unpaired t test)
Table 1 Number of genes up- and down-regulated in the canine





>Fivefold up-regulateda 61 34
>Twofold up-regulated 447 206
>Fivefold down-regulatedb 25 16
>Twofold down-regulated 332 148
aWhen the expression level of each sample in the hemorrhage group (n=3)
is more than fivefold or twofold of that in the control group (n=3)
bWhen the expression level of each sample in the hemorrhage group
(n=3) is less than one fifth or half of that in the control group (n=3)
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that on day 0, was 53.0 ± 7.0% in the hemorrhage group
(P=0.006, paired t test; Fig. 1). The animals that received
double injections did not show any clinical symptoms.
Up- and down-regulated genes in the canine basilar artery
after subarachnoid hemorrhage
On the canine microarray we used, the number of all genes
(probes) was 23,914 and that of named genes was 10,071.
Four hundred forty-seven genes were up-regulated more
than twofold, of which 206 are named. Sixty-one genes
were up-regulated more than fivefold, of which 34 genes
are named. Three hundred thirty-two genes were down-
regulated more than twofold, of which 148 genes are
named. Twenty-five genes were down-regulated more than
fivefold, of which 16 genes are named (Table 1).
Classification of up- and down-regulated genes according
to the gene ontology
Classification of the 206 up-regulated and 148 down-
regulated named genes according to gene ontology is
shown in Table 2 (p<0.01). Based on the analysis using
the GeneSpring software, several gene ontology categories
were identified as being overrepresented. Among the up-
regulated genes, 27 genes were related to cell communication
Table 2 Classification of genes up- and down-regulated more than twofold according to gene ontology
Gene ontology Number of overlapping genes P value GO
Cell communication (GO, 0007154) 27 5.28E-10 BP
Host–pathogen interaction (GO, 003083) 20 7.65E-8 BP
Defense response (GO, 0006952) 13 0.000183 BP
Peptidase activity (GO, 0008233) 14 0.000351 MF
Response to external stimulus (GO, 0009605) 10 0.00142 BP
Catalytic activity (GO, 0003824) 30 0.0015 MF
Cell-cell signaling (GO, 0007267) 9 0.00193 BP
Response to abiotic stimulus (GO, 0009628) 9 0.00467 BP
Cell recognition (GO, 0008037) 9 0.00505 BP
Hydrolase 14 0.00549 MF
Signal transducer activity 13 0.00594 MF
Receptor activity (GO, 0004872) 13 0.00594 MF
Developmenta 12 0.00219 BP
Genes up- and down-regulated more than twofold were classified according to gene ontology (GO, p<0.01, Fisher’s exact test).
GO gene ontology, BP biological process, MF molecular function, CC cellular component
a Down-regulated
Table 3 Most significantly altered named genes in the canine basilar artery after subarachnoid hemorrhage
Accession no. Gene name Average ratio (H/C)
gb:D16413.1 Immunoglobulin E receptor alpha chain 288.93
affx:DG31-116g21-1036m15.r1ca Pancreatitis-associated protein 1 precursor 67.66
gb:AF349533.1 Interleukin-1 beta 61.28
gb:U10308.1 Interleukin-8 60.37
affx:DG25-2g14-748g14.r1ca Haptoglobin alpha and beta chains 37.00
affx:DG18-1c17-544b9.r1ca Immunoglobulin-alpha heavy chain C region 31.78
affx:DG42-63j1-1157a10.r1ca Serum amyloid A protein precursor 23.72
gb:U12234.1 Interleukin-6 22.96
affx:DG32-151m20-900e20.r1ca Cytochorme P450 2A19 0.04
affx:DG14-55j21-971e11.r1ca AGENCOURT_8124351 Lupski_dorsal_root_ ganglion Homosapiens c 0.05
affx:DG34-2h12-790h12.r1ca Interferon stimulated gene 17 0.06
affx:DG2-131h7-132h8.r1ca Cadherin 18, type 2 0.07
affx:DG11-58f10-847o6.r1ca Renal organic anion transporter 1 (rbOAT1) 0.08
a Average ratio was calculated by dividing the mean signal of hemorrhage group with the mean signal of the control group (H/C). The most altered
genes are selected from the top of H/C among >fivefold up- and down-regulated named genes on Table 1.
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(p=5.28E-10): 20 to host–pathogen interaction (7.65E-8), 13
to defense–immunity protein activity (0.000183), 14 to
peptidase activity (0.000351), ten to response to external
stimulus (0.00142), and 30 to catalytic activity (0.0015).
Among the down-regulated genes, 12 genes were related to
development (p=0.00219).
More than fivefold up- and down-regulated genes
Table 3 shows the most significantly altered genes among
the 34 and 16 named genes (probes) that were up- and
down-regulated more than fivefold in the canine basilar
artery after subarachnoid hemorrhage. Genes related to
inflammation, immunological reaction, and stress response
were significantly up-regulated, such as immunoglobulin E
receptor alpha chain, pancreatitis-associated protein 1
precursor, interleukin (IL)-1 beta, IL-8, haptoglobin alpha
and beta, immunoglobulin-alpha heavy-chain C region,
serum amyloid A protein precursor, and IL-6.
Biological network and pathway analysis
Two highly significant networks with a score ≥24 were
identified from the imported data set. After merging the two
networks, the pathway contained 88% of all imported genes
(29 out of 33; Fig. 2). Four major nodes are evident in this
network: IL-8, IL-6, chemokine ligand 2 (CCL2), and
hepatocyte growth factor (HGF), two of which are also
found in Table 3, depicting the genes that are over fivefold
up- or down-regulated (IL-8, IL-6). All major nodes are
connected to each other and to other proteins with a large
number of interactions. The function with the highest
Fig. 2 Functional network analysis relevant in the vasospasm model.
Network map of molecular interactions and subcellular distribution of
involved genes composed of two subnetworks that have an over-
lapping node. Nodes represent genes, with their shapes representing
the functional classes of the gene products, and edges indicate the
biologic relationship between the nodes, which include physical and
functional interactions. The node color indicates up- (red) and down-
regulation (green)
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association significance within the merged network was cell
signaling. Specifically, the regulation of the quantity of Ca2+
(p=4.75E-16; Table 4): 19 genes associated with the quantity
of calcium regulation were located within the pathway
(A4GALT, BDKRB1, CCL2, CCR6, EDG2, EDG4,
EDG7, EGF, F2, HGF, IL4, IL6, IL8, MS4A2, NPY, PPY,
PTGER3, TGFB1, and TNF; boldfacing indicates genes of
the test set, all overexpressed except for EGF, which was
underexpressed). If canonical pathways are overlaid on the
merged network, the p38MAPK pathway is associated with
the highest number of genes present. Four genes of the
p38MAPK pathway were located in the merged network
(TNF, TGFB1, CREB1, RPSKA4), although these were not
over- or underexpressed in the current data set.
Discussion
The genome-wide screening for changes in levels of mRNA
of cerebral artery in the canine double-hemorrhage model
revealed that the transcript alterations were caused by
biological pathways such as cell communication, host–
pathogen interaction, and defense immunity protein activity.
Genes that belong to these reactions include highly up-
regulated molecules associated with inflammation such as
IL-8, IL-6, and IL-1β. Immunoglobulin E receptor alpha
chain, pancreatitis-associated protein 1 precursor, haptoglobin
alpha and beta chains, immunoglobulin-alpha heavy chain C
region, and serum amyloid A protein precursor are also
significantly up-regulated at the time of vasospasm.
Four major nodes are evident in the merged network: IL-8,
IL-6, CCL2, and HGF, all connected to each other and
showing a large number of interactions. The top high-level
function for the merged network was cell signaling, revealing
the subgroup that regulates the quantity of Ca2+ to have the
strongest association significance.
There is no direct evidence of persistent increase of
intracellular Ca2+ in smooth muscle cells in vasospasm [7,
10, 13]. Although nimodipine and other calcium antagonists
showed evidence of reducing poor patient outcome related to
cerebral vasospasm, the nimodipine therapy did not show
any affect on the vessel caliber seen on angiography. The
effects are rather mediated by other factors such as neuro-
protection or the promotion of collateral pial circulation [7,
10]. Therefore, a Ca2+-independent mechanism through the
inhibition of myosin phosphatase induced by Rho kinase,
protein kinase C, and arachidonic acid have been proposed
for the main pathogenesis of cerebral vasospasm [5, 13, 17].
Tani and Matsumoto, however, suggested that the character-
istic feature of vasospasm is a continuous elevation of
intracellular Ca2+ levels in the cerebral artery, as indicated by
the continuous activation of μ-calpain and Ca2+/calmodulin-
dependent myosin light chain kinase phosphorylation of the
myosin light chain [17].
We recently reported that cerebral vasospasm after
subarachnoid hemorrhage can be completely prevented by
an L-type voltage-dependent calcium antagonist in humans
[9, 10]. Tani and Matsumoto speculated that the prevention of
intracellular Ca2+ elevation leads to an inhibition of myosin
light chain kinase, calpain, and protein kinase C, thereby
suppressing the occurrence of cerebral vasospasm [17]. Our
genome-wide network-based analysis in the canine cerebral
vasospasmmodel also showed evidence for calcium playing a
key role in the changes of gene expression. Our conclusions
are limited because the RNA was extracted from the entire
Table 4 High-level function for the merged network in canine cerebral vasospasm (p<E-7)
Process
annotation
Category P value Genes
Quantity of Ca2+ Cell signaling, molecular transport,
and vitamin and mineral metabolism
4.75E-16 A4GALT, BDKRB1, CCL2, CCR6, EDG2, EDG4, EDG7, EGF, F2,
HGF, IL4, IL6, IL8, MS4A2, NPY, PPY, PTGER3, TGFB1, TNF
Quantity of
eicosanoid
Molecular transport 1.68E-9 EGF, F2, IGF2, IL2, IL4, PTGS1, TGFB1, TNF
Quantity of calcium Cell signaling, molecular transport,
and vitamin and mineral metabolism
3.07E-8 BDKRB1, CCL17, DRD2, EGF, F2, IGF2, IL2, IL4, IL6, IL8, NPY,
TGFB1, TNF




Molecular transport 9.29E-8 EGF, F2, IGF2, IL2, PTGS1, TNF
Mobilization of
calcium
Cell signaling, molecular transport,
and vitamin and mineral metabolism
4.31E-7 CCL2, CCL17, CCR6, CD4, EDG2, EDG4, F2, IL8, MS4A2,
NPY1R, TNF
Flux of calcium Cell signaling, molecular transport,
and vitamin and mineral metabolism
4.08E-7 CCL2, CCL17, DRD2, EGF, F2, IL4, IL6, IL8, TNF
Release of
eicosanoid
Molecular transport 1.78E-7 CCL2, DRD2, EGF, IL4, IL8, MS4A2, PTGS1, TNF
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artery wall, and the sources of altered genes include not only
smooth muscle but endothelial, adventitia, and any inflam-
matory cells attached to or within the artery. However, the
changes in gene expression indicate those of smooth muscle
cells, at least in part, because the ratio of smooth muscle cells
in the arterial wall represents the majority. Moreover, similar
gene expression changes have been found in smooth muscle
cells in vitro after the treatment of hemolysate [15].
Among the up-regulated genes, we should focus on IL-8,
IL-6, CCL2, and HGF, which are nodes with most
connections in the network analysis. IL-8 and IL-6 also
belong to the cell communication and host–pathogen
interaction classification of gene ontology. As expected,
the genome-wide cDNA microarray confirmed overexpres-
sions of IL-8 and IL-6 in accordance to the results we had
obtained in past independent experiments [1, 15].
The production of the protein is regulated by intra-
cellular signaling pathways involved in the activation of
p38MAPK. The p38MAPK pathway was associated with
the highest number of genes present in the current study
when canonical pathways were overlaid on the merged
network. In a recent publication, we reported that hemoly-
sate induced the prominent up-regulation of IL-1α, IL-1β,
and IL-8 in human vascular smooth muscle cells in vitro,
which was suppressed by FR167653, a selective inhibitor
of p38MAPK. The intravenous administration of FR167653
also prevents cerebral vasospasm by suppression of
p38MAPK phosphorylation and inhibition of the overexpres-
sion of inflammatory cytokines [15]. The L-type voltage-
dependent Ca2+ channel, a main regulator of intracellular
Ca2+ in the vascular smooth muscle cells, is tightly regulated
by a range of signal transduction pathways in addition to
regulation by its intrinsic, voltage-dependent gating process-
es [4]. As a positive feedback system was reported between
cytokine synthesis and cascade phosphorylation of intracel-
lular kinases, there may be a strong relationship between
intracellular Ca2+ and cytokines [12, 15].
In conclusion, microarray analysis followed by gene
ontology profiling and connectivity analysis identified
several functional groups and individual genes responding
to canine cerebral vasospasm. Among them, calcium
regulation may play a key role on these gene expression
changes and may be involved in the pathogenesis of
cerebral vasospasm.
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Comments
Ute Felbor, Würzburg, Germany
The pathogenesis of cerebral vasospasm after subarachnoid
hemorrhage remains unknown. Sasahara et al. have used genome-
wide canine oligonucleotide microarray analyses to investigate
alterations in gene expression in the basilar artery wall 7 days after
induction of hemorrhage in a canine model. A decrease in vessel
caliber of basilar arteries was accompanied by an up- and down-
regulation of diverse genes. Network analyses demonstrated a
significant association with molecules belonging to Ca2+ cell signaling
and the p38 MAPK stress response pathway. Although the approach
chosen may have documented late-stage changes of the disease
process rather than early, disease-causing pathomechanisms, the
results support an important role for intracellular Ca2+ homeostasis
given the inconclusive effects of calcium antagonists on cerebral
vasospasm.
Kazuhiko Nozaki, Shiga, Japan
The authors investigated the changes of gene expression on
cerebral vasospasm in canine subarachnoid hemorrhage model. They
used genome-wide microarray and analyzed the data by focusing on
up-regulated and down-regulated genes, and using a network-based
analysis. They concluded that Ca signaling might be a candidate for
clarifying the pathogenesis of cerebral vasospasm. This paper provides
us with useful implications for further studies in terms of molecular
networks and related genes. On the other hand, there are some
limitations. They used non-injected day 0 animals as a control. The
data from animals that received plasma or Ringer’s solution may be a
good counterpart to analyze gene expression in delayed vasospasm.
They only analyzed animals on day 7 (when vasospasm reaches its
peak). The time course of gene expression might be important to
analyze the role of each gene and network, and clarify the
pathogenesis of cerebral vasospasm.
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